1. Home
  2. PHAR vs CCNE Comparison

PHAR vs CCNE Comparison

Compare PHAR & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$15.40

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

HOLD

Current Price

$28.23

Market Cap

818.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAR
CCNE
Founded
1988
1865
Country
Netherlands
United States
Employees
N/A
950
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
818.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PHAR
CCNE
Price
$15.40
$28.23
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$39.00
$32.00
AVG Volume (30 Days)
18.4K
121.3K
Earning Date
03-12-2026
04-13-2026
Dividend Yield
N/A
2.62%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.04
$23.21
Revenue Next Year
$2.70
$7.00
P/E Ratio
$3,041.22
$11.84
Revenue Growth
N/A
N/A
52 Week Low
$7.50
$19.32
52 Week High
$21.34
$30.84

Technical Indicators

Market Signals
Indicator
PHAR
CCNE
Relative Strength Index (RSI) 50.07 53.37
Support Level $14.88 $23.52
Resistance Level $17.29 $28.32
Average True Range (ATR) 0.69 0.80
MACD 0.07 0.00
Stochastic Oscillator 53.55 77.41

Price Performance

Historical Comparison
PHAR
CCNE

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About CCNE CNB Financial Corporation

CNB Financial Corp is a Pennsylvania-chartered bank. The bank is a full-service bank engaging in a full range of banking activities and services for individual, business, governmental and institutional customers. These activities and services principally include checking, savings, and time deposit accounts; real estate, commercial, industrial, residential and consumer loans; and a variety of other specialized financial services. Its Private Client Solutions division offers a full range of client services, including private banking and wealth and asset management. The banking segment derives its revenue through the operations as a full-service bank services, including trust and wealth management services, for individual, business, governmental, and institutional customers.

Share on Social Networks: